Cell Culture Market To Witness Growth Based On Enhanced Need For Vaccine Research & Development & Protein Production Till 2022:Grand View Research,inc.
The global cell culture market is expected to reach USD 37.0
billion by 2022, according to a new report by Grand View Research, Inc. This
expected growth in demand can be ascribed to the growing need for
biopharmaceutical development, vaccine research and development, and protein
production; all of which rely heavily on cytological R&D in which cell
culture plays a pivotal role.
The development and
commercialization of integrated robotic liquid handling laboratory automation
culture systems is also expected to considerably enhance growth over the
forecast period. These systems provide highly improved capacity handling,
higher efficiency and reproducible purity levels.
North America cell culture
market, by application, 2012 to 2022 (USD Million)
Browse full research report on
Cell
Culture Market Analysis:
Further key findings from the report suggest:
- Cell culture
sera accounted for over 50% of revenue generated in 2014 owing to, high
usage rates of serum in the composition of cell cultures and their
relatively high average market prices. Furthermore, commercialization of
serum free sera is also expected to drive market demand in the coming years.
- Culture
reagents including amino acids, cofactors, thrombin, and growth factors,
even though used in trace quantities, account for a considerably large
share of revenue owing to their relatively expensive prices.
- North America
accounted for the largest share of this market in 2014, as there are a
significantly high number of research and development projects ongoing in
the region related to cytological investigation for proteomics, genomics,
and drug and vaccine development. Growing need for biopharmaceuticals is
also anticipated to fuel regional market growth during the forecast
period.
- Rising
demand, for cell culture technology and cell biology research in Europe
has shown significant development and companies have started investing in
innovative technologies and advances in cell culture applications.
- Asia Pacific
is expected to witness significant growth in demand over the forecast
period owing to the presence of high unmet need for increasing production
and development of vaccines, drugs, and new biologics. Supportive
government initiatives pertaining to increasing investments by
manufacturers and governments in biopharmaceutical manufacturing and high
untapped market opportunities are some important factors accounting for
such rapid growth in demand.
- Key
participants of the cell culture market include Sartorius, Thermo Fisher
Scientific, General Electric, Merck, Sigma-Aldrich Co., LLC, Corning,
Lonza, Promocell, Becton, Dickinson & Company, and Eppendorf.
- Market
participants are involved in extensive R&D of 3D cell culture and full
commercialization of the technologically advanced cell culture which offer
higher accuracy of replication, greater purity and rapid growth
Comments
Post a Comment